Biocon, Zentiva get EU approval for generic diabetes, weight management drugBiocon Ltd and Zentiva have secured decentralised procedure approval in the EU for Liraglutide, a complex formulation used for diabetes and...
24 Dec, 2024, 11.07 AM IST
Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivotWeight-loss drugs: Biocon Ltd. is shifting focus to anti-obesity therapies as patents for key medications expire, leading to a surge in gen...
08 Apr, 2024, 09.25 AM IST
Sanofi India Q2 results: Co reports net profit at Rs 178 croreRevenue from operations of the company stood at Rs 789.1 crore for the quarter under consideration. It was Rs 710.5 crore for the same peri...
27 Jul, 2021, 04.54 PM IST
Sanofi's valuations are attractive: Why it is stock pick of weekSanofi India’s management has adopted cost control measures and has lowered promotional spends, which was visible in 2020. Its digital push...
04 May, 2021, 09.52 AM IST
Sanofi India Q2 results: Reports net profit of Rs 133 crConsolidated revenue from operations stood at Rs 686.6 crore for the quarter under consideration. It was Rs 779.1 crore for the same period...
27 Oct, 2020, 06.04 PM IST
Sanofi India Q2 results: Net profit at Rs 136.3 croreRevenue from operations stood at Rs 710.5 crore for the quarter under consideration.
28 Jul, 2020, 07.13 PM IST
Add Sanofi India, target price Rs 7,680: CentrumRevenue growth excluding export for the domestic business continues to be at mid-high single digits.
26 May, 2020, 08.52 AM IST
Analysts slash Sanofi target over Ankleshwar plant saleThe stock ended flat at ₹5,928 on Friday.
16 Sep, 2019, 01.40 PM IST
Lupin, Cipla, other top drugmakers in fray for Novartis’ brandsThe Novartis portfolio includes top-selling brand TOBI Podhaler, a drug prescribed for symptomatic relief to patients suffering from cystic...
31 Mar, 2017, 01.06 AM IST
Should Daiichi Sankyo rechristen Ranbaxy?Daiichi Sankyo, the beleaguered Japanese owner of the drug maker, may be tempted to debate whether it is time to rechristen its Indian unit.
10 Jun, 2013, 01.44 AM IST
- Sanofi-Aventis scans India for acquisitions
Sanofi-Aventis which bought companies in Brazil, Mexico, and the home-grown Shanta Biotech this year, has sent a delegation to India to fin...
26 Sep, 2009, 03.25 AM IST
- Piramal Health up 13% on Sanofi stake buy
The news of French drug major Sanofi-Aventis picking up stake in Piramal Healthcare at a premium has resulted in its stock price trading at...
26 Feb, 2009, 11.08 AM IST
- Sanofi seen ahead in Piramal race
Sanofi-Aventis has completed due diligence and the deal could be closed soon, one of the two persons told ET on condition of anonymity.
26 Feb, 2009, 03.34 AM IST
- GSK enters JV for generics push
UK-based GSK on Thursday entered into an alliance with South African generic firm Aspen Pharma to sell the latter’s generic drugs in severa...
26 Jul, 2008, 02.18 AM IST
- Zentiva recommends shareholders reject Sanofi Aventis' bid
The board of Czech generic drugs maker Zentiva N.V. said it has recommended that its shareholders reject a takeover offer from French pharm...
18 Jul, 2008, 06.13 PM IST
- Glenmark sets up company in Romania; aims US$ 50 mn revenue
Glenmark Pharmaceuticals on Tuesday said it has incorporated a company in Romania for its speciality pharmaceutical business and hopes to a...
04 Mar, 2008, 05.09 PM IST
- Mylan buys Merck’s generics unit
Mylan Laboratories agreed to buy Merck KGaA’s generic-drug unit for 4.9 billion euros ($6.7 billion) in cash to become the world’s third-la...
14 May, 2007, 12.20 AM IST